Rapport Therapeutics, Inc.(RAPP:US)
Market Cap$1.418B
Key Metrics
Price$29.57
Revenue (TTM)$20M
Holders Revenue (TTM)$5K
Gross Profit (TTM)-
Earnings (TTM)-$137.16M
EBITDA (TTM)-$152.56M
Op. Margin (TTM)-767.58%
Dividend Yield-
Holders Yield0.00035%
Cash on hand$63.61M
Total Assets$458.98M
Net Assets$422.93M
Total Debt$10.11M
Key Metrics
Price$29.57
Revenue (TTM)$20M
Holders Revenue (TTM)$5K
Gross Profit (TTM)-
Earnings (TTM)-$137.16M
EBITDA (TTM)-$152.56M
Op. Margin (TTM)-767.58%
Dividend Yield-
Holders Yield0.00035%
Cash on hand$63.61M
Total Assets$458.98M
Net Assets$422.93M
Total Debt$10.11M
Financials
| Name | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $0 | $20M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| $60.81M | $44.22M | $38.51M | $29.99M | $29.5M | $27.11M | $23.52M | $21.64M | $20.8M | $17.09M | $14.79M | $9.56M | $6.63M | $5.19M | |
| Research and Development | $51.41M | $32.72M | $30.26M | $22.28M | $22.68M | $19.57M | $17.2M | $15.54M | $15.69M | $12.5M | $11.8M | $7.58M | $4.72M | $3.9M |
| Selling, General, and Administrative | $9.39M | $11.5M | $8.25M | $7.71M | $6.82M | $7.54M | $6.32M | $6.1M | $5.11M | $4.59M | $3M | $1.98M | $1.91M | $1.29M |
| Other Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income | -$60.81M | -$24.22M | -$38.51M | -$29.99M | -$29.5M | -$27.11M | -$23.52M | -$21.64M | -$20.8M | -$17.09M | -$14.79M | -$9.56M | -$6.63M | -$5.19M |
| $4.19M | $4.36M | $4.75M | $3.06M | $2.76M | $3.05M | $3.54M | $4.1M | $2.68M | -$5.58M | $1.28M | $856K | $221K | -$955K | |
| Non-Operating Interest Income | $4.19M | $4.36M | $4.75M | $3.06M | $2.76M | $3.05M | $3.54M | $4.1M | $2.68M | $1.82M | $1.38M | $856K | $221K | $75K |
| Non-Operating Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Income/Expense | - | - | - | - | - | - | $0 | - | - | -$7.39M | -$94K | - | - | -$1.03M |
Income Before Tax | -$56.62M | -$19.86M | -$33.76M | -$26.93M | -$26.73M | -$24.06M | -$19.98M | -$17.54M | -$18.12M | -$22.67M | -$13.51M | -$8.71M | -$6.41M | -$6.15M |
Income Tax | - | - | - | - | - | - | $0 | $0 | $0 | $0 | $6K | $1K | $2K | $1K |
Net Income | -$56.62M | -$19.86M | -$33.76M | -$26.93M | -$26.73M | -$24.06M | -$19.98M | -$17.54M | -$18.12M | -$22.67M | -$13.52M | -$8.71M | -$6.41M | -$6.15M |
Minority Interests | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Preferred Stock Dividends | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income to Common | -$56.62M | -$19.86M | -$33.76M | -$26.93M | -$26.73M | -$24.06M | -$19.98M | -$17.54M | -$18.12M | -$22.67M | -$13.52M | -$8.71M | -$6.41M | -$6.15M |
Shares Outstanding (Basic) | 47.47M | 47.24M | 46.98M | 37.93M | 35.44M | 35.27M | 35.07M | 34.86M | 10.67M | 24.19M | - | 24.19M | 24.19M | 24.19M |
Shares Outstanding (Diluted) | 47.47M | 47.24M | 46.98M | 37.93M | 35.44M | 35.27M | 35.07M | 34.86M | 10.67M | 24.19M | - | 24.19M | 24.19M | 24.19M |
EPS (Basic) | -$1.19 | -$0.42 | -$0.72 | -$0.71 | -$0.75 | -$0.68 | -$0.57 | -$0.50 | -$1.70 | -$0.94 | - | -$0.36 | -$0.26 | -$0.25 |
EPS (Diluted) | -$1.19 | -$0.42 | -$0.72 | -$0.71 | -$0.75 | -$0.68 | -$0.57 | -$0.50 | -$1.70 | -$0.94 | - | -$0.36 | -$0.26 | -$0.25 |
EBIT | -$60.81M | -$24.22M | -$38.51M | -$29.99M | -$29.5M | -$27.11M | -$23.52M | -$21.64M | -$20.8M | -$17.09M | -$13.39M | -$9.56M | -$6.63M | -$5.19M |
EBITDA | -$60.59M | -$23.99M | -$38.24M | -$29.73M | -$29.24M | -$26.86M | -$23.26M | -$21.42M | -$20.59M | -$16.94M | -$13.34M | -$9.54M | -$6.61M | -$4.15M |